BL Pharmtech Corp. (KOSDAQ:065170)
South Korea
· Delayed Price · Currency is KRW 2,985.00
-160.00 (-5.09%)
At close: Mar 6, 2026
BL Pharmtech Revenue
BL Pharmtech had revenue of 906.85M KRW in the quarter ending September 30, 2025, a decrease of -64.58%. This brings the company's revenue in the last twelve months to 6.98B, down -41.58% year-over-year. In the year 2024, BL Pharmtech had annual revenue of 8.81B, down -64.10%.
Revenue (ttm)
6.98B
Revenue Growth
-41.58%
P/S Ratio
11.79
Revenue / Employee
581.43M
Employees
12
Market Cap
82.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.81B | -15.72B | -64.10% |
| Dec 31, 2023 | 24.53B | 2.00B | 8.89% |
| Dec 31, 2022 | 22.52B | -61.92B | -73.33% |
| Dec 31, 2021 | 84.44B | 18.75B | 28.54% |
| Dec 31, 2020 | 65.69B | 6.82B | 11.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Polaris AI Pharma | 63.94B |
| GL Pharm Tech | 34.30B |
| Hwail Pharmaceutical | 107.87B |
| Sinsin Pharmaceutical | 110.29B |
| Optipharm.CO.,LTD | 21.98B |
| Ahn-Gook Pharmaceutical | 300.96B |
| Daehan Nupharm | 201.59B |
| Sinil Pharmaceutical | 80.97B |